Tech Company Financing Transactions
Relievant Medsystems Funding Round
Relievant Medsystems secured a $50 million Series G funding round on 4/19/2023. Investors included Ally Bridge Group, Canaan Partners and Endeavour Vision.
Transaction Overview
Company Name
Announced On
4/19/2023
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series G
Investors
Proceeds Purpose
The company will use the funds to Advance the Treatment for Chronic Vertebrogenic Low Back Pain.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
8500 Normandale Lakes Blvd. 2150
Minneapolis, MN 55437
USA
Minneapolis, MN 55437
USA
Phone
Website
Email Address
Overview
Relievant MedSystems is a medical device company developing novel products to treat lower back pain using a minimally invasive therapeutic approach. The company was founded in 2004 and is headquartered in San Francisco, California.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kevin Hykes
Chief Financial Officer
Chris Geyen
Chief Medical Officer
Ray Baker
Chief Operating Officer
Alex DiNello
Vice President
Mary Hailey
VP - R & D
Brian Donovan
VP - Regulatory Affairs
Diane Sahr
VP - Sales
Kirk Ellis
Browse more venture capital transactions:
Prev: 4/19/2023: Lexion venture capital transaction
Next: 4/19/2023: E-magy venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs